Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kalydeco
Biotech
Eloxx stock slumps lower on failed phase 2 cystic fibrosis trial
Eloxx failed a midphase clinical trial, dragging its battered share price down further still and leaving the future of the program in doubt.
Nick Paul Taylor
Sep 15, 2022 5:40am
Vertex, Concert orchestrate $250M phase 2 CF drug deal
Mar 6, 2017 7:23am
Vertex experimental CF PhIII combo trial pulled after weak results
Aug 16, 2016 6:23am
